GIM
BMY icon

Greylin Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Greylin Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,115
Closed -$223K – 83
2024
Q1 		$223K Sell
4,115
-750
-15% -$38.2K 0.04% 76
2023
Q4 		$250K Buy
+4,865
New +$255K 0.04% 68
2014
Q4 		– Sell
-3,950
Closed -$202K – 63
2014
Q3 		$202K Buy
+3,950
New +$197K 0.05% 64
2014
Q2 		– Sell
-5,150
Closed -$268K – 69
2014
Q1 		$268K Sell
5,150
-1,074
-17% -$57.1K 0.07% 61
2013
Q4 		$331K Sell
6,224
-276
-4% -$14.1K 0.08% 62
2013
Q3 		$301K Hold
6,500
– – 0.15% 32
2013
Q2 		$290K Buy
+6,500
New +$282K 0.09% 34

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greylin Investment Management's BMY Position: Q2 2024 in Review

Greylin Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,115 shares — an estimated $223K sold.

Greylin Investment Management first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $331K in Q4 2013. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Greylin Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Greylin Investment Management sold 4,115 Bristol-Myers Squibb shares in Q2 2024, an estimated $223K.
  • Greylin Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
  • Greylin Investment Management's Bristol-Myers Squibb position peaked at $331K in Q4 2013.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.